Status:
COMPLETED
HPV Centralized R/R RCT #2 - New York State
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Cancer Institute (NCI)
University of Colorado, Denver
Conditions:
Vaccines
Eligibility:
All Genders
11-14 years
Phase:
NA
Brief Summary
The work done in this trial builds off of the work previously conducted by this same research group in clinicaltrials.gov ID: NCT03057379. Due to some changes in study design, protocol, and cohort of ...
Detailed Description
The overarching goal is to evaluate the effectiveness, cost effectiveness, and sustainability of statewide immunization systems (IISs) to conduct reminder/recall (R/R) to improve human papillomarvirus...
Eligibility Criteria
Inclusion
- 11 to 14 years of age
- patient of a participating practice in New York State (practices were randomly selected)
- is due for an HPV dose at baseline, or
- has initiated but not yet completed the HPV series at baseline
- immunization record within the New York State Immunization Information System (NYSIIS) database
Exclusion
- is not a patient of a participating practice that was randomly selected in New York State
- has completed the HPV vaccination series
- does not have a valid record within the NYSIIS database
Key Trial Info
Start Date :
October 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 5 2019
Estimated Enrollment :
37003 Patients enrolled
Trial Details
Trial ID
NCT03294551
Start Date
October 27 2017
End Date
November 5 2019
Last Update
May 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90095